By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

FibroBiologics, Inc. Common Stock (FBLG)

NASDAQ Currency in USD
$0.56
+$0.02
+3.94%
Last Update: 11 Sept 2025, 20:00
$23.66M
Market Cap
-2.28
P/E Ratio (TTM)
Forward Dividend Yield
$0.53 - $4.14
52 Week Range

FBLG Stock Price Chart

Explore FibroBiologics, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze FBLG price movements and trends.

FBLG Company Profile

Discover essential business fundamentals and corporate details for FibroBiologics, Inc. Common Stock (FBLG) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

1 Feb 2024

Employees

13.00

CEO

Peter O'Heeron

Description

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

FBLG Financial Timeline

Browse a chronological timeline of FibroBiologics, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 Nov 2025

EPS estimate is -$0.10.

Earnings released on 31 Jul 2025

EPS came in at -$0.12 falling short of the estimated -$0.11 by -9.09%.

Earnings released on 31 Mar 2025

EPS came in at -$0.09 surpassing the estimated -$0.10 by +10.00%.

Earnings released on 27 Mar 2025

EPS came in at -$0.09 surpassing the estimated -$0.10 by +5.73%.

Earnings released on 12 Nov 2024

EPS came in at -$0.08 matching the estimated -$0.08.

Earnings released on 7 Aug 2024

EPS came in at -$0.09 matching the estimated -$0.09.

Earnings released on 14 May 2024

EPS came in at -$0.27 .

Earnings released on 31 Dec 2023

EPS came in at -$0.34 .

Earnings released on 30 Sept 2023

EPS came in at -$0.07 .

Earnings released on 30 Jun 2023

EPS came in at -$0.07 .

Earnings released on 31 Mar 2023

EPS came in at -$0.07 .

Earnings released on 31 Dec 2022

EPS came in at -$0.05 .

Earnings released on 29 Sept 2022

EPS came in at -$0.05 .

Earnings released on 30 Jun 2022

EPS came in at -$0.04 .

Earnings released on 31 Mar 2022

EPS came in at -$0.04 .

FBLG Stock Performance

Access detailed FBLG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run